Joanne M Bowen

16PUBLICATIONS
32CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesPsychosocial aspects of childbirth and perinatal mental healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 01, 2026
Development of a Tumor-Bearing Animal Model to Evaluate Chemotherapy Efficacy and Toxicity.

|Apr 20, 2026
Author response to OSIN-D-26-00399 bone protection in breast cancer: durability and discontinuation.

|Mar 14, 2026
A novel cabozantinib formulation with improved safety and bioavailability: preclinical validation in rats.

Shangwei Qin, Yu Zhang, John Duan

|Feb 16, 2026
Effectiveness and safety of bone protective interventions to mitigate bone loss and skeletal fractures experienced by patients with non-metastatic breast cancer: a systematic review and meta-analysis.

Micaela J Quinn, Bonnie Williams, Tania N Crotti

|Oct 14, 2025
Blautia luti reduces neratinib-induced diarrhea in a rat model.

Claire P Vieyra, Micaela J Quinn, Emma H Bateman

|Aug 26, 2024
Preclinical and clinical evaluation through serial colonoscopic evaluation of neratinib-induced diarrhea in HER2-positive breast cancer-A pilot study.

Joanne Bowen, Sofia Braga, Valeria Dal Zotto

Pageof 3

Frequent Collaborators

5 joint publications

Hannah R Wardill

3 joint publications

Micaela J Quinn

3 joint publications

Emma H Bateman

2 joint publications

Ysabella Za Van Sebille